Publications

[20/10/2023] Single-Masked Randomized Phase 2 Study Assessing 2 Forms of Hypofractionated Proton Therapy in Patients With Large Choroidal Melanomas.

[03/03/2023] Visual outcomes of macular melanocytic lesions after early or delayed proton beam therapy

[09/11/2022] QUANTITATIVE ANALYSIS OF CHORIOCAPILLARIS ALTERATIONS IN SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY-ANGIOGRAPHY DURING RADIATION RETINOPATHY

[26/09/2022] Indocyanine Green Angiography Features in Acute Syphilitic Posterior Placoid Chorioretinitis

[15/06/2022] Disorganization of the inner retinal layers in diabeticmacular edema: systematic review

[23/03/2022] Non-Cancer Effects following Ionizing Irradiation Involving the Eye and Orbit. Cancers 2022, 14, 1194.

[07/11/2021] Lux study: Contribution of a three-dimensional, high dynamic range, ultra-high-definition heads-up visualization system to a significant delivered light intensity decrease during different types of ocular surgeries

[09/09/2021] Intravitreal aflibercept in routine clinical practice: 12-month results from the French cohort of treatment-naïve patients with macular edema secondary to retinal vein occlusion in the AURIGA study

[01/09/2021] Peripheral retinal lesions in handheld laser maculopathy

[31/03/2021] One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema

[24/02/2021] Multicenter Evaluation of Time, Operational, and Economic Efficiencies of a New Preloaded Intraocular Lens Delivery System versus Manual Intraocular Lens Delivery

[01/12/2020] Patient experience of anti-Vegf Intravitreal Injection

[10/09/2020] Interest of observational period before treat and extend treatment in exsudative AMD

[08/06/2020] COMPARATIVE EFFECTIVENESS OF PROTON BEAM VERSUS PHOTODYNAMIC THERAPY TO SPARE THE VISION IN CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.

[01/05/2020] Management of vitreous floaters: an international survey the European VitreoRetinal Society Floaters study report

[04/12/2019] Diagnosis and treatment of peripheral exudative haemorrhagic chorioretinopathy.

[10/10/2019] Management of uveal melanomas, guidelines for oncologists

[06/09/2019] National survey on the management and information practices of patients with wet AMD.

[06/09/2019] Film Lasso Technique Euretina Congress Paris

[06/09/2019] HULC Study Poster Euretina Congress Paris 2019.

Heads Up Learning Curve with 3D system surgical system
Laurent VELASQUE, M LAPEYRE, M DOMINGUEZ, E FOURMAUX, L ROSIER, C SEGUY.

[06/09/2019] LUX Study Poster Euretina Congress Paris 2019.

Laurent VELASQUE , A HANDAYE DESSUS, M DOMINGUEZ, E FOURMAUX, L ROSIER, C SEGUY.
Contribution of a heads-up system with a low light sensitive camera to a significant decrease of the endoillumination during ocular surgeries, compensated by the brightness of the screen

[01/09/2019] Effectiveness and safety of intravitreal aflibercept in patients with wet age- related macular degeneration treated in routine clinical practices across France: 12-month outcomes of the RAINBOW study

[04/04/2019] Pitfalls and diagnostic difficulties in detecting bilateral macular edema. Ophthalmo logical Realities . 20 19 ; 259 : 50 -1

[17/02/2019] The Lens Opacities Classification System III grading in irradiated uveal melanomas to characterize proton induced cataracts.

[27/09/2018] EURETINA 2018 Communication

[14/02/2018] Cataract Avoidance with Proton Therapy in Ocular Melanomas

[10/05/2017] Poster ARVO 2017 Baltimore USA

[07/05/2017] Poster ARVO 2017 Batimore USA

[05/05/2017] Communication SFO the RAINBOW Study Real-Life Use of Intravitreal Aflibercept In France: observational study in Wet Age-Related Macular Degeneration:

[10/02/2017] Poster ASCRS Maastricht

[15/01/2017] Ultrasert Study APACRS Congress

[23/09/2016] Visual Outcomes of Parapapillary Uveal Melanomas following Proton beam Therapy

[01/09/2016] ARVO Annual Meeting Abstract September 2016 Real Life Use of Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study

• ARVO Annual Meeting Abstract September 2016
• Real Life Use of Aflibercept In France: Observational study in Wet AMD: the RAINBOW study 
  OUBRAHAM-MEBROUKINE Hassiba; Celine Faure; Florence Coscas; Thi Ha Chau Tran; Benedicte Briend-Joulain; Laurent Velasque; Isabelle Aubry; Michel Weber; Salomon Y Cohen
• Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):524.

[04/05/2016] Poster ARVO 2016 :

[03/05/2016] Poster ARVO 2016 :

[16/11/2015] Corrigendum to Strategy for the Management of Diabetic Macular Edema

[06/11/2015] Intravitreal ranibizumab combined with verteporfin photodynamic therapy in the management of wet age-related macular degeneration in routine clinical practice in France: the AURORE study.

[01/09/2014] Clinical variables associated with failure of retinal detachment repair: the European vitreo-retinal society retinal detachment study report number 4.

[03/05/2014] Poster ARVO 2014 :

[07/09/2013] Comparison of clinical efficacy: Nd:YAG laser rates after implantation of AcrySof® SN60WF, Akreos® AO-MI60 and Hoya® YA-60BB.

Bourdiol Ducasse AM, Guerzider V, Velasque L, Dominguez M, Lafuma A, Robert J. J Fr Ophtalmol. 2013 Sep;36(7):575-82

[02/09/2013] Strategy for the management of complex retinal detachments: the European vitreo-retinal society retinal detachment study report 2.

[01/09/2013] Strategy for the management of uncomplicated retinal detachments: the European vitreo-retinal society retinal detachment study report 1.

[05/05/2012] Poster ARVO 2012 :

[06/09/2008] 8th European VitreoRetinal Society congress, Prague

[01/10/2006] BEST disease. Ophthalmoscopic and OCT views

[01/11/2005] Spontaneous retrohyaloid hemorrhage treated with YAG laser].

Velasque L, Dominguez M, Rosier L.
J Fr Ophtalmol. 2005 Nov;28(9):1007.

[25/09/2005] Complications and lack of benefit after transpupillary thermotherapy for occult choroidal neovascularization: 1-year results

[19/04/2004] Laser photocoagulation for choroidal neovascular membrane associated with optic disc

[30/06/1999] Results of proton therapy of uveal melanomas treated in Nice.

[30/06/1994] Technical considerations about protontherapy and visual conservation for uveal melanomas: The experience of the SERAG.